Anne Landais
Anne Landais has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Annie Lannuzel
Paris Brain Institute‐ICM, Inserm, CNRS, Hôpital de la Pitié Salpêtrière Sorbonne Université Paris France
2 shared publications Benoit Guillon
Department of Neurology, Nantes University Hospital, Nantes, France
2 shared publicationsChristian Denier
Department of Neurology, CHU Kremlin Bicêtre, Paris, France
2 shared publicationsDonald Accrombessi
Neurology Department/ CHU Guadeloupe
2 shared publicationsEmmanuelle Robinet-Borgomano
Department of Neurology, Hôpital de La Timone, Marseille University Hospital, Marseille, France
2 shared publicationsFernando Pico
Department of Neurology, Versailles Hospital, Versailles, France
2 shared publications
Latest Publications
- 9 October 2023
- Published by SAGE Publications in International Journal of Stroke
- Vol. 19 (2) , 180-188
Clinical, imaging, and management features of symptomatic carotid web: Insight from CAROWEB registry
Background: Although carotid web (CaW) is increasingly diagnosed as a cause of cryptogenic stroke, data are still limited to monocentric small sample cohort. To broaden knowledge on symptomatic CaW, CAROWEB registry has been recently implemented. Aims: In a large cohort of symptomatic CaW patients, we described epidemiologic characteristics, admission clinical and imaging features, and the current management including the secondary preventive strategy choice made in comprehensive French Stroke Units. Methods: CAROWEB is an ongoing French observational multicenter registry enrolling consecutive CaW patients diagnosed after an ipsilateral ischemic stroke (IS) or transient ischemic attack (TIA). Submitted cases were validated by two experienced neurologist and neuroradiologist. Clinical, imaging, and management features were collected for this study. Results: Between June 2019 and December 2021, 244 cases were submitted by 14 centers, 42 rejected, and 202 included (IS, 91.6%; TIA, 7.9%; retinal infarction, 0.5%; mean age, 50.8 ± 12.2 years; female, 62.9%; Caucasian, 47.5%; Afro-Caribbean, 20.3%). IS patients showed median (interquartile range (IQR)) admission National Institutes of Health Stroke Scale (NIHSS) score, 8 (2–15); intracranial artery occlusion, 71.8%; ipsilateral chronic cerebral infarction (CCI), 16.3%; and reperfusion treatment, 57.3%. CaW was not identified during the mechanical thrombectomy procedure in 30 of 85 (35.3%) patients. Secondary prevention was invasive in 55.6% (stenting, n = 80; surgery, n = 30). In multivariable analysis, the invasive therapeutic option was associated with ipsilateral CCI (odds ratio (OR): 4.24 (1.27–14.2), p = 0.019) and inversely associated with risk factors (OR: 0.47 (0.24–0.91), p = 0.025) and admission NIHSS score (OR: 0.93 (0.89–0.97), p = 0.001). Conclusion: CaW must be considered in all ethnic groups including Caucasians. Secondary prevention is heterogeneous in large French Stroke Centers. The absence of risk factors, milder severity strokes, and ipsilateral CCI were predictive variables of secondary invasive treatment. The high rate of invasive treatment suggests that medical treatment alone is deemed ineffective to avoid recurrence and emphasize the need of randomized trials.
- 9 October 2023
- Published by SAGE Publications in International Journal of Stroke
- Vol. 19 (2) , 180-188
Clinical, imaging, and management features of symptomatic carotid web: Insight from CAROWEB registry
Background: Although carotid web (CaW) is increasingly diagnosed as a cause of cryptogenic stroke, data are still limited to monocentric small sample cohort. To broaden knowledge on symptomatic CaW, CAROWEB registry has been recently implemented. Aims: In a large cohort of symptomatic CaW patients, we described epidemiologic characteristics, admission clinical and imaging features, and the current management including the secondary preventive strategy choice made in comprehensive French Stroke Units. Methods: CAROWEB is an ongoing French observational multicenter registry enrolling consecutive CaW patients diagnosed after an ipsilateral ischemic stroke (IS) or transient ischemic attack (TIA). Submitted cases were validated by two experienced neurologist and neuroradiologist. Clinical, imaging, and management features were collected for this study. Results: Between June 2019 and December 2021, 244 cases were submitted by 14 centers, 42 rejected, and 202 included (IS, 91.6%; TIA, 7.9%; retinal infarction, 0.5%; mean age, 50.8 ± 12.2 years; female, 62.9%; Caucasian, 47.5%; Afro-Caribbean, 20.3%). IS patients showed median (interquartile range (IQR)) admission National Institutes of Health Stroke Scale (NIHSS) score, 8 (2–15); intracranial artery occlusion, 71.8%; ipsilateral chronic cerebral infarction (CCI), 16.3%; and reperfusion treatment, 57.3%. CaW was not identified during the mechanical thrombectomy procedure in 30 of 85 (35.3%) patients. Secondary prevention was invasive in 55.6% (stenting, n = 80; surgery, n = 30). In multivariable analysis, the invasive therapeutic option was associated with ipsilateral CCI (odds ratio (OR): 4.24 (1.27–14.2), p = 0.019) and inversely associated with risk factors (OR: 0.47 (0.24–0.91), p = 0.025) and admission NIHSS score (OR: 0.93 (0.89–0.97), p = 0.001). Conclusion: CaW must be considered in all ethnic groups including Caucasians. Secondary prevention is heterogeneous in large French Stroke Centers. The absence of risk factors, milder severity strokes, and ipsilateral CCI were predictive variables of secondary invasive treatment. The high rate of invasive treatment suggests that medical treatment alone is deemed ineffective to avoid recurrence and emphasize the need of randomized trials.
- Open Access
- 11 September 2023
- Published by Gavin Publishers in International Journal of Cerebrovascular Disease and Stroke
- Vol. 6 (1)
PRES Secondary to the LenvatinibPembrolizumab Combination in a Patient with Serous Endometrial Adenocarcinoma
Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder of (sub) acute onset characterized by varied neurological symptoms [1].
- 11 September 2023
- Published by Gavin Publishers in International Journal of Cerebrovascular Disease and Stroke
- Vol. 6 (1)
Open AccessPRES Secondary to the LenvatinibPembrolizumab Combination in a Patient with Serous Endometrial Adenocarcinoma
Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder of (sub) acute onset characterized by varied neurological symptoms [1].
- 27 March 2023
- Published by Elsevier in Revue Neurologique
- Vol. 179, S117-S118
Diaphragmes carotidiens en échographie doppler des troncs supra aortiques
- 27 March 2023
- Published by Elsevier in Revue Neurologique
- Vol. 179, S117-S118
Diaphragmes carotidiens en échographie doppler des troncs supra aortiques
- 20 December 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (4) , 444-448
Dual-layer carotid stenting for symptomatic carotid web: Results from the Caroweb study
- 20 December 2022
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 50 (4) , 444-448
Dual-layer carotid stenting for symptomatic carotid web: Results from the Caroweb study
- 1 July 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 402, 180-187
Fingolimod for the treatment of multiple sclerosis in French West Indies, a real-world study in patients from African ancestry
- 1 July 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 402, 180-187
Fingolimod for the treatment of multiple sclerosis in French West Indies, a real-world study in patients from African ancestry
- 1 June 2016
- Published by Elsevier in Neurochirurgie
- Vol. 62 (3) , 165-170
Psychiatric comorbidity in temporal DNET and improvement after surgery
- 1 June 2016
- Published by Elsevier in Neurochirurgie
- Vol. 62 (3) , 165-170
Psychiatric comorbidity in temporal DNET and improvement after surgery